Skip to main content
About Us
Our Credo
Board of Directors
Committees of the Board
Management Council
Sustainability
Manufacturing
Quality
Code of Conduct
Our History - Cipla Archives
Milestones and Awards
Our Presence
Australia
Brazil
Europe
Kenya
Malaysia
Morocco
Nepal
South Africa
Spain
Sri Lanka
United Kingdom
USA
Our Offerings
Our Therapies
Respiratory
Asthma
Paediatric Asthma
COPD
Nebulization
HIV/AIDS
Oncology
Other Therapies
Cipla Generics
Products
Easylax
Easylax-L
OTC – Cipla Health
Cipla Diagnostics
API
Covid Care
Investors
Financials & Filings
Quarterly Results
Investor Presentation
Annual Reports
Scheme of Arrangement
Corporate Governance
Disclosure under regulation 46 of SEBI LODR
Cipla at a Glance
Board Of Directors
Committees of the Board
Investor Resources
Shareholding Pattern
Intimation to Stock Exchange
Unclaimed Data
Investor Contact
Disclaimer
Careers
Life at Cipla
Business Functions
Diversity & Inclusion
Holistic Wellbeing
Cipla University
Join Us
Media Centre
Media Releases
In The News
Leaders Speak
Corporate Social Responsibility
Cipla Foundation
CSR Policy
CSR Committee
Approved CSR Projects
2023-24
2022-23
2021-22
Contact Us
Global
Brazil
Kenya
South Africa
Sri Lanka
United Kingdom
USA
Return Home
×